Scientific program - 2012 International Conference on Diabetes and ...

Corporate symposiaLuncheon symposium 1 (Sponsored by JW pharmaceutical)Diabetic dyslipidemia - statins & beyond statinsFriday 9 Nov. 12:20~13:40, Convention Hall A, 4FChair : You Hern AhnHiroaki Okazaki (The University of Tokyo, Japan)Corporate symposiaFriday 9 Nov. 12:20~13:40, Convention Hall B, 4FLuncheon symposium 2 (Sponsored by MSD)Chair : Chung Gu ChoAdvantages of incretin therapy for type 2 diabetes mellitus including Korean patientsKyung Mook Choi (Korea University, Korea)Friday 9 Nov. 12:20~13:40, Convention Hall C, 4FLuncheon symposium 3 (Sponsored by Novartis)Chair : Dong-Sun KimEvidence for vildagliptin as a therapeutic option for type 2 diabetes: efficacy considerationsEun Gyoung Hong (Hallym University, Korea)Luncheon symposium 4 (Sponsored by Boehringer Ingelheim)DPP-4 inhibitors: beyond glycemic control in diabetes treatmentFriday 9 Nov. 12:20~13:40, Emerald Hall, 3FChair : Dong-Seop ChoiYoung Min Cho (Seoul National University, Korea)Luncheon symposium 5 (Sponsored by Sanofi-aventis)ORIGIN-what can we learn from this landmark trial?Saturday 10 Nov. 12:20~13:30, Convention Hall A, 4FChair : Ho Young SonJeong Taek Woo (Kyung Hee University, Korea)Saturday 10 Nov. 12:20~13:30, Convention Hall B, 4FLuncheon symposium 6 (Sponsored by Lilly)Chair : Yeon Ah SungTargeting post-prandial glucose control: metabolic and clinical implicationsEun Jung Rhee (Sungkyunkwan University, Korea)Saturday 10 Nov. 12:20~13:30, Convention Hall C, 4FLuncheon symposium 7 (Sponsored by Daewoong)Chair : Joong-Yeol ParkFactors predicting therapeutic efficacy of combination treatment with sitagliptin and metformin in type 2diabetic patients: the COSMETIC studySoo Lim (Seoul National University, Korea)18<strong>2012</strong> <strong>International</strong> <strong>Conference</strong> on Diabetes and Metabolism